| Verastem Bucks the Trend, Raises $55M in IPO | Luke Timmerman | 01/26/12 | Boston |
| Verastem Lands $20,102,609 New Funding Round | VentureDeal | 11/11/11 | Boston |
| Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 | Luke Timmerman | 11/07/11 | National |
| This Week’s Xconomy Report on WGBH: Zuckerberg’s Change of Heart, IDing Adults Online, Vocal Cord Repair, and Verastem IPO | Lilly O'Flaherty | 11/04/11 | Boston |
| Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News | Erin Kutz | 11/04/11 | Boston |
| VC Investment in MA Companies Falls Back to Earth (from $1B to $505M): Top 10 Q3 Deals | Gregory T. Huang | 10/24/11 | Boston |
| Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News | Erin Kutz | 07/15/11 | Boston |
| Verastem, Rooted at MIT, Raises $32 Million and Adds ATV and Astellas to Slate of Investors | Arlene Weintraub | 07/14/11 | Boston |
| Verastem Obtains $32,000,000 Series B Financing Round | VentureDeal | 07/14/11 | Boston |
| Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News | Erin Kutz | 06/24/11 | Boston |
| Termeer Joins Verastem Board | Luke Timmerman | 06/13/11 | Boston |
| Stemline Makes Headway Against Cancer Stem Cells And Proves Value of Virtual Model | Arlene Weintraub | 06/08/11 | New York |
| Top 10 List of Boston-Area VC Deals for Q4 2010: NinePoint, 1366, Rive, and More | Gregory T. Huang | 01/24/11 | Boston |
| Rich Aldrich, Biotech Powerbroker, Breaks Silence on New $87M Longwood Founders Fund | Ryan McBride | 01/06/11 | Boston |
| SCVNGR Scares Up $15M, Genocea Gets $35M, Zeo Zeros in on $12.3M, & More Boston-Area Deals News | Rebecca Zacks | 01/05/11 | Boston |
| Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News | Erin Kutz | 11/19/10 | Boston |
| Verastem, Founded by MIT Big Names, Raises $16M to Fight Cancer Stem Cells | Luke Timmerman | 11/16/10 | Boston |
| Verastem Secures $16,000,000 Series A Round | VentureDeal | 11/16/10 | Boston |
